Literature DB >> 6348067

Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome.

M R Taskinen, E A Nikkilä, R Pelkonen, T Sane.   

Abstract

Plasma lipoproteins, triglyceride turnover, and lipolytic enzymes were measured in 11 women with Cushing's syndrome. The studies were repeated 3 and 12 months after surgical treatment. Eleven healthy women of similar age and relative body weight served as controls. Before treatment the mean values of total cholesterol and triglyceride, of very low-density lipoprotein (VLDL) triglyceride and cholesterol, low density lipoprotein triglyceride and cholesterol, and high density lipoprotein cholesterol were all significantly increased in the patients with Cushing's syndrome. The triglyceride levels were only moderately elevated, the highest values being found in patients with adrenocortical adenoma. The production rate of VLDL triglyceride was higher in patients (13.2 mg/h . kg) than in controls (9.5 mg/h . kg, P less than 0.05), whereas the fractional catabolic rate of VLDL triglyceride was not significantly different. Consistent with the latter finding, the lipoprotein lipase activities of adipose tissue, skeletal muscle, and postheparin plasma were similar in patients and controls. The postheparin plasma hepatic lipase activity of the patients was at the lower end of the normal range. All lipid and lipoprotein abnormalities were completely abolished after successful surgery. It is concluded that endogenous hypercortisolism stimulates the hepatic production of VLDL particles. The effect is probably based on multifactorial mechanisms. In the presence of unchanged removal this leads to elevated levels of VLDL, low density lipoprotein, and high density lipoprotein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348067     DOI: 10.1210/jcem-57-3-619

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.

Authors:  Xuewen Wang; Faidon Magkos; Bruce W Patterson; Dominic N Reeds; Janine Kampelman; Bettina Mittendorfer
Journal:  Eur J Endocrinol       Date:  2012-05-22       Impact factor: 6.664

Review 2.  Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues.

Authors:  Rucha Patel; Jasmine Williams-Dautovich; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-04-25

3.  Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.

Authors:  Stephanie T Page; Ronald M Krauss; Coleman Gross; Brian Ishida; Jay W Heinecke; Chongren Tang; John K Amory; Peter M Schaefer; Cheryl J Cox; John Kane; Jonathan Q Purnell; Richard L Weinstein; Tomáš Vaisar
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

4.  Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone.

Authors:  P Martin-Sanz; J E Vance; D N Brindley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

5.  Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.

Authors:  D Belkebir-Mesbah; D Bonnefont-Rousselot; V Frey-Fressart; C Moinard; J Delattre; M P Vasson
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

6.  Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation.

Authors:  Sandip K Bose; Irina Hutson; Charles A Harris
Journal:  Endocrinology       Date:  2016-10-18       Impact factor: 4.736

7.  Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study.

Authors:  Karina Danilowicz; Oscar Domingo Bruno; Marcos Manavela; Reynaldo Manuel Gomez; Ariel Barkan
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

8.  Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

Authors:  Janice M Paterson; Nicholas M Morton; Catherine Fievet; Christopher J Kenyon; Megan C Holmes; Bart Staels; Jonathan R Seckl; John J Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

9.  Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes.

Authors:  E H Mangiapane; D N Brindley
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

10.  Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes.

Authors:  Wilco W M Fleuren; Margot M L Linssen; Erik J M Toonen; Gerard C M van der Zon; Bruno Guigas; Jacob de Vlieg; Wim H A Dokter; D Margriet Ouwens; Wynand Alkema
Journal:  Arch Physiol Biochem       Date:  2013-03-19       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.